U.S. markets closed

  • S&P Futures

    4,342.50
    -9.50 (-0.22%)
     

  • Dow Futures

    34,795.00
    -69.00 (-0.20%)
     

  • Nasdaq Futures

    14,752.75
    -34.75 (-0.23%)
     

  • Russell 2000 Futures

    2,180.50
    -6.30 (-0.29%)
     

  • Crude Oil

    71.50
    -0.15 (-0.21%)
     

  • Gold

    1,830.80
    +1.80 (+0.10%)
     

  • Silver

    26.43
    +0.04 (+0.16%)
     

  • EUR/USD

    1.1820
    +0.0001 (+0.01%)
     

  • 10-Yr Bond

    1.2970
    -0.0590 (-4.35%)
     

  • Vix

    17.01
    +0.68 (+4.16%)
     

  • GBP/USD

    1.3833
    +0.0010 (+0.07%)
     

  • USD/JPY

    109.7400
    -0.1000 (-0.09%)
     

  • BTC-USD

    31,727.35
    -1,022.81 (-3.12%)
     

  • CMC Crypto 200

    768.81
    -17.62 (-2.24%)
     

  • FTSE 100

    7,012.02
    -79.17 (-1.12%)
     

  • Nikkei 225

    28,279.09
    0.00 (0.00%)
     

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of GP Strategies Corporation (NYSE - GPX)

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BALA CYNWYD, PA / ACCESSWIRE / July 15, 2021 / Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of GP Strategies Corporation ("GP Strategies" or the "Company") (NYSE:GPX) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the agreement to be acquired by Learning Technologies Group. ("LTG"). Under the terms of the merger agreement, GP Strategies shareholders will receive only $20.85 in cash for each share of GP Strategies they own.

The investigation concerns whether the GP Strategies Board breached its fiduciary duties to GP Strategies shareholders and whether LTG is paying too little for the Company.

If you own shares of GP Strategies stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, visit https://www.brodskysmith.com/cases/gp-strategies-corporation-nyse-gpx/, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC



View source version on accesswire.com:
https://www.accesswire.com/655721/SHAREHOLDER-NOTICE-Brodsky-Smith-Announces-an-Investigation-of-GP-Strategies-Corporation-NYSE--GPX

Recommended Stories

  • Why NVIDIA Stock Just Dropped 4%

    What happened Shares of graphics (and crypto-mining) chipmaker NVIDIA (NASDAQ: NVDA) tumbled for a third straight day Thursday, falling 4% in 1:25 p.m. EDT trading despite getting a boost in its price target from Wall Street bank Mizuho.

  • Bond King Jeff Gundlach says there is a simple reason Treasury yields are so low even as inflation surges

    Bond guru Jeffrey Gundlach of DoubleLine Capital said it is no mystery why U.S. Treasury yields are anchored lower despite evidence that inflation is rising in an economy attempting to rebound from a stultifying pandemic.

  • NVIDIA Stock Could Crash. Here's What You Should Do if It Does

    As graphics card prices start sliding, NVIDIA investors may have to relive a torrid time in the company's history.

  • Why Moderna Stock Is Hitting Another Record High Today

    Shares of Moderna (NASDAQ: MRNA) were jumping 4.3% as of 11:10 a.m. EDT on Thursday, hitting another record high for the stock. The bump came after Michael Yee, an analyst at Jefferies, increased his price target on the stock from $170 to $250. Also, Dr. Marco Cavaleri, the European Medicines Agency (EMA) head of biological health threats and vaccines strategy, stated in a press conference that a committee would likely finalize a decision on recommending authorization for Moderna's COVID-19 vaccine in children by the end of next week.

  • 'We think that there’s going to be more upside to Apple here': Citi's Jim Suva

    Jim Suva, Citi Managing Director in Equity Research specializing in technology, joined Yahoo Finance Live to break down his thoughts ont he outlook of Apple. 

  • Expect a 10% or worse correction in U.S. stocks by mid-August, says this forecaster with a proven track record

    In May 2020, I concluded that “the stock market… is stronger than even the most bullish investors believe.” In January of this year, I wrote that the market was still “firing on all cylinders.” In an interview on July 14, Martin said the U.S. stock market today is most definitely not firing on all cylinders. In fact, he said, the market’s internal health is now worse than at any time since October 2018.

  • Why Is Lordstown Motors Stock Higher Today?

    Shares of embattled electric pickup start-up Lordstown Motors (NASDAQ: RIDE) were trading higher on Thursday. In March, short-seller Hindenburg Research alleged that Lordstown (among other things) exaggerated the number of pre-orders it had for its Endurance pickup truck. Lordstown denied the allegations, but the Securities and Exchange Commission opened an investigation.

  • 10 Best Safe Blue Chip Dividend Stocks

    In this article, we will be looking at the 10 best safe blue chip dividend stocks. If you want to skip our detailed analysis of blue chips stocks and dividend investing, you can go directly to the 5 Best Safe Blue Chip Dividend Stocks. If you’re looking for a stock that’s reliable, renowned, and reputable, […]

  • Why Virgin Galactic Shares Fell This Week

    Virgin Galactic Holdings (NYSE: SPCE) completed a historic milestone last Sunday, successfully launching founder Richard Branson into space. Branson's flight into space happened nearly a year after it was originally planned, due to a combination of COVID-related delays and some testing setbacks. Richard Branson (second from left) and the mission specialists ahead of the July 11 flight.

  • Why Is Everyone Talking About General Electric Stock?

    General Electric (NYSE: GE) stock is sitting in the middle of a battleground of bulls and bears. The bears point out that the stock is up less than 12% compared to the near 50% gain in the S&P 500 since October 2018, when Larry Culp took over as GE's CEO. GE is a company that remains poorly run despite Culp's efforts, and faces significant end market challenges in aviation (slow recovery in commercial air flights) and power (weak demand for gas turbines over renewable energy).

  • My Top Oil Stock to Buy Right Now

    When you look at the oil industry, this European giant still stands out as the best mix of risk and reward.

  • Citigroup Just Raised Its Price Target on AMD Stock by 459%. Here’s Why.

    Analyst Christopher Danely upgraded his call on AMD to Neutral from Sell, and bumped his price target to $95 from $17. The loser: Intel.

  • Better Electric Vehicle Charging Stock: ChargePoint or Blink Charging

    Similarly, ChargePoint (NYSE: CHPT) stock is up roughly 155% since it announced plans to go public via a special purpose acquisition company last September. To begin with, ChargePoint is bigger than Blink Charging in terms of number of charging stations, revenue, and market share.

  • Why Plug Power, Nikola, and JinkoSolar Stocks Popped Today

    Plug just barely, while Nikola's 3.4% and Jinko's 4.5% gains remain more respectable. In the case of Plug Power, the answer is easy: An upgrade -- or more precisely, a new buy rating, from Seaport Global Securities, which initiated coverage of the $26 stock today with a price target of $36.

  • 3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street

    Despite the stock market hitting seemingly one new high after another since the year began, Wall Street still sees value in equities. Based on the highest Wall Street price target for each of the following small-cap stocks, implied upside ranging from 158% to as much as 329% may await. The first tiny tot that Wall Street appears to be really excited about is clinical-stage biotech stock Vaxart (NASDAQ: VXRT).

  • Why Transocean Rocketed Higher in the First Half of 2021

    Shares of Transocean (NYSE: RIG) nearly doubled over the first six months of 2021, rising 95.7%, according to data from S&P Global Market Intelligence, as market conditions and interest in ultra-deepwater projects continue to improve as the global economy emerges from the pandemic. The offshore drilling rig supplier recently had to delay delivery of two next-generation drillships because the energy industry's recovery is not linear. Transocean has a backlog of business worth $7.4 billion, indicating its customers are none too worried.

  • Why Appian, Fastly, Fiverr, and LivePerson All Fell This Week

    Shares of Appian (NASDAQ: APPN), Fastly (NYSE: FSLY), Fiverr International (NYSE: FVRR), and LivePerson (NASDAQ: LPSN) were all sliding this week as high-priced growth stocks largely pulled back on inflation concerns. There was no major news out on these stocks, but with June's consumer price index report showing inflation was hotter than expected, fears of tightening monetary policy from the Federal Reserve seemed to have cooled off these pricey stocks. Through Thursday at 1:19 p.m EDT, Appian was down 13.9% for the week, Fastly had lost 12.6%, Fiverr had given up 12.5%, and LivePerson was down 9.9%.

  • 10 Best Dividend Kings to Buy Now According to Hedge Funds

    In this article, we will be looking at the 10 best dividend kings to buy now according to hedge funds. If you want to skip our detailed analysis of dividend investing, you can go directly to the 5 Best Dividend Kings to Buy According to Hedge Funds. The economic and financial volatility that came as […]

  • EV Charging Stock Jumps On Expanded GM Alliance

    GM expanded its new EV charging service to include commercial vehicles and named EVgo a preferred partner.

  • Moderna Climbs as S&P 500 Set to Welcome Covid Vaccine Maker

    (Bloomberg) -- Moderna Inc. climbed more than 6% in extended trading Thursday after the vaccine maker was named to the S&P 500 Index in one of the most noteworthy additions to the index since Tesla Inc. joined late last year.The company, whose messenger-RNA vaccine has helped to fight the Covid-19 pandemic, will replace Alexion Pharmaceuticals Inc. in the benchmark U.S. index before the opening of trading on July 21. Alexion is set to be acquired by U.K. drugmaker AstraZeneca Plc.Shares of Moder